AI-Generated Acne Vulgaris Learning Material Study

June 11, 2026 updated by: Hasan Durmuş

Evaluating AI-Generated Educational Material for Acne Vulgaris Learning Among Early-Year Medical Students: A Comparative Educational Intervention Study

This comparative educational intervention study evaluated the educational effectiveness of artificial intelligence-generated patient information material on acne vulgaris among early-year medical students. In the first phase, acne vulgaris information texts were generated using different artificial intelligence models and evaluated by two dermatologists using quality and understandability assessment tools. In the second phase, the best-performing artificial intelligence-generated material was compared with standard human-generated material from the Turkish Dermatology Association and a control group. A total of 190 first- and second-year medical students at Erciyes University Faculty of Medicine participated in the study. Participants were divided into three groups: artificial intelligence-generated material group, Turkish Dermatology Association material group, and control group. After the educational materials were presented, participants completed a 12-question knowledge assessment questionnaire on acne vulgaris.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

190

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Kayseri
      • Kayseri, Kayseri, Turkey (Türkiye), 38000
        • Erciyes University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • First- and second-year medical students enrolled at Erciyes University Faculty of Medicine
  • Voluntary participation in the study
  • Provision of informed consent

Exclusion Criteria:

  • Students who declined to participate
  • Students who did not complete the knowledge assessment questionnaire
  • Students with incomplete study data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Artificial Intelligence-Generated Material Group
Participants received educational material on acne vulgaris generated by the best-performing artificial intelligence model.
Other: Artificial Intelligence-Generated Acne Vulgaris Educational Material
Educational material on acne vulgaris generated using an artificial intelligence model and presented to participants.
Active Comparator: Turkish Dermatology Association Material Group
Participants received standard human-generated educational material on acne vulgaris provided by the Turkish Dermatology Association.
Other: Turkish Dermatology Association Acne Vulgaris Educational Material
Standard human-generated educational material on acne vulgaris provided by the Turkish Dermatology Association and presented to participants.
No Intervention: Control Group
Participants did not receive the educational material before completing the knowledge assessment questionnaire.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acne Vulgaris Knowledge Score
Time Frame: Immediately after the educational intervention
Acne vulgaris knowledge level was assessed using a 12-question knowledge assessment questionnaire administered after the educational intervention.
Immediately after the educational intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hasan Durmuş

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2025

Primary Completion (Actual)

December 15, 2025

Study Completion (Actual)

March 15, 2026

Study Registration Dates

First Submitted

June 11, 2026

First Submitted That Met QC Criteria

June 11, 2026

First Posted (Actual)

June 16, 2026

Study Record Updates

Last Update Posted (Actual)

June 16, 2026

Last Update Submitted That Met QC Criteria

June 11, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ERU-AIACNE-2025-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be publicly shared due to privacy and ethical considerations. De-identified data may be available from the corresponding author upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acne Vulgaris

Clinical Trials on Artificial Intelligence-Generated Acne Vulgaris Educational Material

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe